Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography

Metabolism: Clinical and Experimental

Volumn 61, Issue 12, 2012, Pages 1763-1770

  Tsubakio Yamamoto, Kazumi ^a   Sugimoto, Taizo ^a   Nishida, Makoto ^b   Okano, Rieko ^c   Monden, Yasumasa ^d   Kitazume Taneike, Rika ^a   Yamashita, Taiji ^a   Nakaoka, Hajime ^a   Kawase, Ryota ^a   Yuasa Kawase, Miyako ^a   Inagaki, Miwako ^a   Nakatani, Kazuhiro ^a   Masuda, Daisaku ^a   Ohama, Tohru ^a   Matsuyama, Akifumi ^e   Nakagawa Toyama, Yumiko ^b   Ishigami, Masato ^a   Komuro, Issei ^a   Yamashita, Shizuya ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA ROSAI HOSPITAL   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

^e FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

6 Insulin sensitivity; Adiponectin; High density lipoprotein; HPLC; Low density lipoprotein

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ASSESSMENT TOOL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMA R; HUMAN; INSULIN RESISTANCE; JAPAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; AGED; APOLIPOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARTICLE SIZE;

EID: 84869489933     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.05.011     Document Type: Article

References (40)

1. M. Rizzo, K. Berneis, and E. Corrado The significance of low-density-lipoproteins size in vascular diseases Int Angiol 25 2006 4 9
2. N.E. Miller, A. La Ville, and D. Crook Direct evidence that reverse cholesterol transport is mediated by high density lipoprotein in rabbit Nature 314 1985 109 111 (Pubitemid 15142032)
3. K. Maeda, K. Okubo, and I. Shimomura cDNA cloning and expression of a novel adipose specific collagen-like factor, aPM1 (adipose most abundant gene transcript 1) Biochem Biophys Res Commun 221 1996 286 289 (Pubitemid 26136463)
4. P.E. Scherer, S. Williams, and M. Fogliano A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
5. N. Ouchi, S. Kihara, and Y. Arita Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476 (Pubitemid 30005109)
6. T. Kazumi, A. Kawaguchi, and K. Sakai Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure Diabetes Care 25 2002 971 976 (Pubitemid 41110480)
7. F. Mallamaci, C. Zoccali, and F. Cuzzola Adiponectin in essential hypertension J Nephrol 15 2002 507 511 (Pubitemid 35396514)
8. S. Engeli, M. Feldpausch, and K. Gorzelniak Association between adiponectin and mediators of inflammation in obese women Diabetes 289 2003 1799 1804
9. N. Ouchi, S. Kihara, and T. Funahashi Obesity, adiponectin and vascular inflammatory disease Curr Opin Lipidol 14 2003 561 566 (Pubitemid 41623184)
10. Y. Miyoshi, T. Funahashi, and S. Kihara Association of serum adiponectin levels with breast cancer risk Clin Cancer Res 9 2003 5699 5704 (Pubitemid 37499493)
11. M. Ryo, T. Nakamura, and S. Kihara Adiponectin as a biomarker of the metabolic syndrome Circ J 68 2004 975 981 (Pubitemid 39540124)
12. F. Matsuura, H. Oku, and M. Koseki Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver Biochem Biophys Res Commun 358 2007 1091 1095 (Pubitemid 46829000)
13. H. Oku, F. Matsuura, and M. Koseki Adiponectin deficiency suppresses ABCA1 expression and apo A-I synthesis in the liver FEBS Lett 581 2007 5029 5033 (Pubitemid 47576080)
14. K. Tsubakio-Yamamoto, F. Matsuura, and M. Koseki Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages Biochem Biophys Res Commun 375 2008 390 394
15. R. Lautamäki, T. Rönnemaa, and R. Huupponen Low serum adiponectin is correlated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease Metabolism 56 2007 881 886 (Pubitemid 46900837)
16. D. Giannessi, C. Caselli, and S.D. Ry Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure Metabolism 60 2011 227 233
17. M. Blüher, M. Fasshauer, and N. Klöting Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training Diabetes Care 30 2007 3110 3115 (Pubitemid 350255258)
18. T. Matsunami, Y. Sato, and S. Ariga Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model Metabolism 60 2011 805 814
19. Barbara V. Howard, Elizabeth J. Mayer-Davis, and David Goff Relationships between insulin resistance and lipoproteins in nondiabetic Africans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study Metabolism 47 1998 1174 1179 (Pubitemid 28469240)
20. W.T. Garvey, S. Kwon, and D. Zheng Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 53 2003 453 462 (Pubitemid 36173203)
21. S. Sam, S. Haffner, and M.H. Davidson Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes Diabetes 57 2008 2022 2027
22. A. Festa, K. Williams, and A.J. Hanley Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study Circulation 111 2005 3465 3472 (Pubitemid 40923401)
23. D.C. Goff Jr., R.B. D'Agostino Jr., and S.M. Haffner Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study Metabolism 54 2005 264 270 (Pubitemid 40174857)
24. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83 (Pubitemid 29299050)
25. D. Masuda, Y. Nakagawa-Toyama, and K. Nakatani Ezetimibe improves postprandial hyperlidaemia in patients with type IIB hyperlipidaemia Eur J Clin Invest 39 2009 689 698
26. M. Okazaki, S. Usui, and S. Hosaki Analysis of plasma lipoproteins by gel permeation chromatography N. Rifai, G.R. Warnick, M.H. Dominiczak, Handbook of lipoprotein testing 2000 AACC Press Washington, DC 647 669
27. S. Usui, M. Nakamura, and K. Jitsukata Assessment of between-instrument variations in an HPLC method for serum lipoproteins on high performance liquid chromatography J Biochem 92 1982 517 524
28. Y. Matsuzawa Metabolic syndrome - definition and diagnostic criteria in Japan J Atheroscler Thromb 12 2005 301
29. M. Okazaki, S. Usui, and M. Ishigami Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profiles in high-performance liquid chromatography Arterioscler Thromb Vasc Biol 25 2005 578 584 (Pubitemid 40315681)
30. H. Kobayashi, T. Nakamura, and K. Miyaoka Visceral fat accumulation contributes to insulin resistance, small sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men Jpn Circ J 65 2001 193 199
31. H. Ruan, and F. Harvey Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha Cytokine Growth Factor Rev 14 2003 447 455 (Pubitemid 37099456)
32. G.K. Shetty, C.S. Mantzoros, and P.A. Economides Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2450 2457 (Pubitemid 39281400)
33. F. Makgos, E. Fabbrini, and B.W. Patterson Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects Metabolism 60 2011 1641 1648
34. D.C. Chan, G.F. Watts, and E.M.M. Ooi Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men Metabolism 60 2011 1482 1487
35. C.S. Mantzoros, T. Li, and J.E. Manson Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in woman with type 2 diabetes J Clin Endocrinol Metab 90 2005 4542 4548 (Pubitemid 41159340)
36. C.L. Addy, A. Gavrila, and S. Tsiodras Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy J Clin Endocrinol Metab 88 2003 627 636 (Pubitemid 36207802)
37. F. Magkos, and C.S. Mantzoros Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment Metabolism 60 2011 749 753
38. A. Brown, P.W. Baker, and G.F. Gibbons Changes in fatty acid metabolism in rat hepatocytes in response to dietary n-3 fatty acids are associated with changes in the intracellular metabolism and secretion of apolipoprotein B-48 J Lipid Res 38 1997 469 481 (Pubitemid 27166690)
39. R. Weiss, J.D. Otvos, and A. Flyvbjerg Adiponectin and lipoprotein particle size Diabetes Care 32 2009 1317 1319
40. Z. Li, J.D. Otvos, and S. Lamon-Fava Men and women differ in lipoprotein response to dietary saturated fat and cholesterol restriction J Nutr 133 2003 3428 3433 (Pubitemid 37409469)